# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3386627 | A | Cytotoxicity against human PBMC cells at 1 to 100 ug/ml after 24 hrs by MTT assay | Homo sapiens | 16 | ALA3352129 | cell-based format | Scientific Literature | |
2. | ALA3386628 | F | Antiproliferative activity against human PBMC assessed as inhibition of PHA-induced proliferation at 1 to 100 ug/ml | Homo sapiens | 16 | ALA3352129 | cell-based format | Scientific Literature | |
3. | ALA3386631 | F | Inhibition of LPS-induced TNFalpha secretion in human whole blood cells at 5 ug/ml by immune assay | Homo sapiens | 3 | ALA3352129 | cell-based format | Scientific Literature | |
4. | ALA3386632 | F | Inhibition of LPS-induced TNFalpha secretion in human whole blood cells at 25 ug/ml by immune assay | Homo sapiens | 4 | ALA3352129 | cell-based format | Scientific Literature | |
5. | ALA3386633 | F | Immunosuppressive effect in ovalbumin-induced mouse delayed type hypersensitivity model assessed as inhibition of DTH reaction at 100 ug, ip treated 2 hrs before ovalbumin sensitization | Mus musculus | 2 | ALA3352129 | organism-based format | Scientific Literature | |
6. | ALA3386634 | F | Antiinflammatory activity in mouse assessed as inhibition of carrageenan-induced foot pad inflammation at 100 ug, ip treated 24 and 2 hrs before carrageenan challenge measured 3 hrs post challenge | Mus musculus | 2 | ALA3352129 | organism-based format | Scientific Literature | |
7. | ALA3386635 | P | Retention time of the compound | 16 | ALA3352129 | small-molecule physicochemical format | Scientific Literature | ||
8. | ALA3386636 | F | Immunosuppressive effect in ovalbumin-induced mouse delayed type hypersensitivity model assessed as inhibition of DTH reaction at 100 ug, ip treated 2 hrs before elicitation of DTH reaction with secoond dose of antigen | Mus musculus | 2 | ALA3352129 | organism-based format | Scientific Literature |